Results 311 to 320 of about 172,791 (358)
Prevalence of Mental Health Symptoms in Chronic Urticaria: A Systematic Review and Meta‐Analysis
Allergy, EarlyView.
Daniel G. Rayner +6 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 1995
Psoriasis is a chronic, genetically influenced, remitting and relapsing scaly and inflammatory skin disorder that affects 1 to 3 percent of the world's population. The diagnosis is made on clinical grounds, although histologic examination of a skin-biopsy specimen may be helpful.
Malcolm W. Greaves, Gerald D. Weinstein
openaire +5 more sources
Psoriasis is a chronic, genetically influenced, remitting and relapsing scaly and inflammatory skin disorder that affects 1 to 3 percent of the world's population. The diagnosis is made on clinical grounds, although histologic examination of a skin-biopsy specimen may be helpful.
Malcolm W. Greaves, Gerald D. Weinstein
openaire +5 more sources
Guselkumab for the treatment of psoriasis
Expert Opinion on Biological Therapy, 2018Psoriasis is a chronic immune mediated disease in which the interplay of T cells and keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 axis is currently considered to be crucial in the pathogenesis of psoriasis and the selective inhibition of IL-23 may be viewed as an improvement of treatments blocking both IL-23 ...
Megna, Matteo +3 more
openaire +5 more sources
Apremilast for the treatment of psoriasis
Expert Opinion on Pharmacotherapy, 2015Psoriasis is a chronic inflammatory skin disease characterized by dysregulation of the immune system and release of pro-inflammatory mediators. Drugs available for psoriasis show some limits as tolerability and route of administration. Apremilast , Otezla®, is an oral small molecule recently approved for the treatment of patients with moderate-to ...
CHIMENTI, MARIA SOLE +8 more
openaire +6 more sources
The Topical Treatment of Psoriasis
Skin Pharmacology and Physiology, 2003According to the patients, improvement of efficacy, long-term safety and improvement of compliance are needed. The topical treatment has been innovated during the last decade. Most important are the introduction of two new classes of treatments: topical vitamin D<sub>3</sub> analogues and the retinoid tazarotene.
Kerkhof, P.C.M. van de +1 more
openaire +3 more sources
Inflammopharmacology, 2008 The treatment of psoriasis has long been a challenge to the dermatologist on several levels. Psoriasis does not respond in any predictable fashion to topical or systemic agents, and to date there are no clinical or laboratory measures to predict response to therapy in an individual.
Kristina P. Callis, Gerald G. Krueger
openaire +3 more sources
New England Journal of Medicine, 1963
PSORIASIS is a familial disease of the skin characterized clinically by an increased production of abnormal scales, resulting from a marked hyperplasia of immature epidermal cells.1 2 3 4 5 6 7 8 9...
openaire +3 more sources
PSORIASIS is a familial disease of the skin characterized clinically by an increased production of abnormal scales, resulting from a marked hyperplasia of immature epidermal cells.1 2 3 4 5 6 7 8 9...
openaire +3 more sources
American Journal of Health-System Pharmacy, 1980
The disease of psoriasis is examined as to its incidence, etiology, clinical manifestations, and possible complications. Drugs that might cause dermatotoxic effects are introduced as possible agents that might precede an acute attack. Topical therapy, the initial approach with most forms of mild to moderate psoriasis, may consist of glucocorticoids ...
openaire +3 more sources
The disease of psoriasis is examined as to its incidence, etiology, clinical manifestations, and possible complications. Drugs that might cause dermatotoxic effects are introduced as possible agents that might precede an acute attack. Topical therapy, the initial approach with most forms of mild to moderate psoriasis, may consist of glucocorticoids ...
openaire +3 more sources
Established Treatments of Psoriasis
Current Drug Target -Inflammation & Allergy, 2004Psoriasis is a complex disease with a spectrum of clinical manifestations. Psoriasis may express as a few coin-sized erythemato-squamous plaques up to widespread disease covering the entire body surface (erythrodermic psoriasis). Psoriasis may present as a few stable plaques or unstable disease, rapidly relapsing after treatment.
Kerkhof, P.C.M. van de +1 more
openaire +4 more sources